Mitochondrial replacement therapy and parenthood

Global Bioethics

Volumn 26, Issue 3-4, 2015, Pages 198-205

  Garasic, Mirko Daniel ^a   Sperling, Daniel ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b The David Yellin Academic College of Education   (Israel)

Author keywords

eugenics; mitochondrial replacement therapy; parenthood; preimplantation genetic diagnosis; reproductive ethics

Indexed keywords

EID: 84949001014     PISSN: 11287462     EISSN: 15917398     Source Type: Journal    
DOI: 10.1080/11287462.2015.1066082     Document Type: Article

References (33)

1. Amato, P., Masahito, T., Sparman, M., & Mitalipov, S., (2014). Three-parent in vitro fertilization: Gene replacement for the prevention of inherited mitochondrial diseases. Fertility and Sterility, 101(1), 31–35. doi: 10.1016/j.fertnstert.2013.11.030
2. Barritt, J. A., Brenner, C. A., Malter, H. E., & Cohen, J., (2001). Mitochondria in human offspring derived from ooplasmic transplantation: Brief communication. Human Reproduction, 16(3), 513–516. doi: 10.1093/humrep/16.3.513
3. Baylis, F., (2013). The ethics of creating children with three genetic parents. Reproductive BioMedicine Online, 26, 531–534. doi: 10.1016/j.rbmo.2013.03.006
4. Border, P., (2013). Preventing mitochondrial disease. POSTnote 431, Retrieved from http://www.parliament.uk/business/publications/research/briefing-papers/POST-PN-431/preventing-mitochondrial-disease
5. Bourne, H., Douglas, T., & Savulescu, J., (2012). Procreative beneficence and in vitro gametogenesis. Monash Bioethics Review, 30, 29–48. doi: 10.1007/BF03351338
6. Bredenoord, A. L., & Braude, P., (2010). Ethics of mitochondrial gene replacement: From bench to bedside. BMJ, 341, c6021. doi: 10.1136/bmj.c6021
7. Council for Responsible Genetics. (2013). Oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility. FDA Public Meeting, October 15.
8. Cutas, D., Dondorp, W., Swierstra, T., Repping, S., & de Wert, G., (2014). Artificial gametes: Perspectives of geneticists, ethicists and representatives of potential users. Medicine, Health Care and Philosophy, 17(3), 339–345.
9. Darnovsky, M., (2013). A slippery slope to human germline modification. Nature, 499(7457), article no. 127. doi:10.1038/499127a
10. Darnovsky, M., (2014). Genetically modified babies. The New York Times. February 23. Retrieved from http://www.nytimes.com/2014/02/24/opinion/genetically-modified-babies.html?_r=0
11. Davis, D. S., (2002). The parental investment factor and the child's right to an open future. The Hastings Center Report, 39(2), 24–27. doi: 10.1353/hcr.0.0125
12. Dimond, R., (2013). Patient and family trajectories of mitochondiral disease: Diversity, uncertainty and genetic risk. Life Sciences, Society and Policy, 9(2). Retrieved from http://www.lsspjournal.com/content/9/1/2
13. Farahany, N., (2014). FDA considers controversial fertility procedure. What's at stake? The Washington Post, February 25. Retrieved from http://www.washingtonpost.com/news/volokh-conspiracy/wp/2014/02/25/fda-considers-controversial-fertility-procedure-whats-at-stake/
14. FDA. (2014). Cellular, tissue, and gene therapies. FDA Advisory Committee Briefing Document. Retrieved from http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm385461.pdf
15. Gallagher, J., (2013). UK government backs three-person IVF. BBC News, June 27. Retrieved from http://www.bbc.co.uk/news/health-23079276
16. Garasic, M. D., (2013). The Singleton case: Enforcing medical treatment to put a person to death. Medicine, Health Care and Philosophy, 16(4), 795–806. doi: 10.1007/s11019-013-9462-8
17. Haites, N., & Lovell-Badge, R., (2011). Human fertilisation and embryology authority report. Retrieved from http://www.hfea.gov.uk/docs/2011-04-18_Mitochondria_review_-_final_report.PDF
18. Hayden, E. C., (2013). Regulators weigh benefits of ‘three-parent’ fertilization. Nature, 502, 284–285. doi: 10.1038/502284a
19. HFEA. (2012). Medical frontiers: Debating mitochondria replacement. Retrieved from http://www.hfea.gov.uk/6896.html
20. Human Fertilisation and Embryology Act. (2008). (c.22). Retrieved from http://www.legislation.gov.uk/ukpga/2008/22/contents
21. Ivanov, P. L., Wadhams, M. J., Roby, R. K., Holland, M. M., Weedn, V. W., & Parsons, T. J., (1996). Mitochondrial DNA sequence heteroplasmy in the Grand Duke of Russia Georgij Romanov establishes the authenticity of the remains of Tsar Nicholas II. Nature Genetics, 12(4), 417–420. doi: 10.1038/ng0496-417
22. Jaarsma, P., & Welin, S., (2013). Human capabilities, mild autism, deafness and the morality of embryo selection. Medicine, Health Care and Philosophy, 16(4), 817–824. doi: 10.1007/s11019-013-9464-6
23. Johnson, M. H., (2013). Tri-parenthood–A simply misleading term or an ethically misguided approach?. Reproductive BioMedicine Online, 26, 516–519. doi: 10.1016/j.rbmo.2013.03.014
24. Loike, J. D., & Fischbach, R. L., (2013). New ethical horizons in gestational surrogacy. J IVF Reprod Med Genet., 1(2), 1–4.
25. Palacios-González, C., Harris, J., & Testa, G., (2014). Multiplex parenting: IVG and the generations to come. J Med Ethics 40, 752–758. doi:10.1136/medethics-2013-101810
26. Parliamentary Assembly. (2013). Creation of embryos with genetic material from more than two progenitor persons. Written declaration No. 557: Doc. 13325. 03 October 2013. Retrieved from http://assembly.coe.int/nw/xml/XRef/Xref-XML2HTML-en.asp?fileid=20204&lang=en
27. Reinhardt, K., Dowling, D. K., & Morrow, E. H., (2013). Mitochondrial replacement, evolution, and the clinic. Science, 341(20), 1345–1346. doi: 10.1126/science.1237146
28. Sandin, S., Nygren, K. C., Iliadou, A., Hultman, C. M., & Reichenberg, A., (2013). Autism and mental retardation among offspring born after in vitro fertilization. JAMA, 310(1), 75–84. doi: 10.1001/jama.2013.7222
29. Sparrow, R., (2014). In vitro eugenics. Journal of Medical Ethics, 40(11), 725–731. doi: 10.1136/medethics-2012-101200
30. Sperling, D., (2011). The therapeutic Triumph: Making poor claims and offering a revised conceptualization to justify embryo selection. Ethical Perspectives, 18(3), 407–440.
31. Tavernise, S., (2014). F.D.A. Weighs fertility method that raises ethical questions. The New York Times. Retrieved from http://www.nytimes.com/2014/02/26/health/fda-meeting-considers-controversial-fertility-procedure.html?hpw&rref=us&_r=1
32. Taylor, R. W., & Turnbull, D. M., (2005). Mitochondrial DNA mutations in human disease. Nature Reviews Genetics, 6, 389–402. doi: 10.1038/nrg1606
33. UK Government. (2014). Serious mitochondrial disease: new techniques to prevent transmission. Retrieved from https://www.gov.uk/government/consultations/serious-mitochondrial-disease-new-techniques-to-prevent-transmission